ARCHIVES

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

This article is from The Cancer Letter archive.

Vol. 24 No. 31 | August 7, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Plastic Surgeon James French Named to NCAB; Clinton Re-Appoints Nienhuis

April 11, 2000

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

Advisors say NCI needs to reach out to other fields.

July 15, 2005

Cancer Policy Board urges distinct care for cancer survivors.

November 11, 2005

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992